Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Overcoming challenges of clinical biomarker development

Annual Congress on Oncology and Biomarkers Summit
November 27-28, 2017 | Atlanta, USA

Xuemei Zhao

Merck Research Laboratories, USA

Posters & Accepted Abstracts : J Med Oncl Ther

Abstract:

The utility of various types of clinical biomarkers is to aid decision-making in drug development. After a pre-clinical candidate is approved for development in clinical studies, biomarker activities are transitioned from discovery to clinical biomarker development and implementation. Clinical biomarker development includes clinical biomarker assay development, fit-for-purpose assay validation, and clinical biomarker qualification in clinical studies. After a clinical biomarker is qualified, it will then be implemented in clinical studies to aid decision-making. Overcoming challenges of clinical biomarker development such as preanalytics, assay selectivity, and matrix effect will be discussed.

PDF HTML

Get the App